A Fast Method for Testing Covariates in Population PK/PD Models

被引:0
|
作者
Akash Khandelwal
Kajsa Harling
E. Niclas Jonsson
Andrew C. Hooker
Mats O. Karlsson
机构
[1] Uppsala University,Department of Pharmaceutical Biosciences
来源
关键词
conditional estimation; covariate model building; NONMEM; population PK/PD;
D O I
暂无
中图分类号
学科分类号
摘要
The development of covariate models within the population modeling program like NONMEM is generally a time-consuming and non-trivial task. In this study, a fast procedure to approximate the change in objective function values of covariate–parameter models is presented and evaluated. The proposed method is a first-order conditional estimation (FOCE)-based linear approximation of the influence of covariates on the model predictions. Simulated and real datasets were used to compare this method with the conventional nonlinear mixed effect model using both first-order (FO) and FOCE approximations. The methods were mainly assessed in terms of difference in objective function values (ΔOFV) between base and covariate models. The FOCE linearization was superior to the FO linearization and showed a high degree of concordance with corresponding nonlinear models in ΔOFV. The linear and nonlinear FOCE models provided similar coefficient estimates and identified the same covariate–parameter relations as statistically significant or non-significant for the real and simulated datasets. The time required to fit tesaglitazar and docetaxel datasets with 4 and 15 parameter–covariate relations using the linearization method was 5.1 and 0.5 min compared with 152 and 34 h, respectively, with the nonlinear models. The FOCE linearization method allows for a fast estimation of covariate–parameter relations models with good concordance with the nonlinear models. This allows a more efficient model building and may allow the utilization of model building techniques that would otherwise be too time-consuming.
引用
收藏
相关论文
共 50 条
  • [1] A Fast Method for Testing Covariates in Population PK/PD Models
    Khandelwal, Akash
    Harling, Kajsa
    Jonsson, E. Niclas
    Hooker, Andrew C.
    Karlsson, Mats O.
    AAPS JOURNAL, 2011, 13 (03): : 464 - 472
  • [2] OPTIMAL DESIGN FOR POPULATION PK/PD MODELS
    Leonov, Sergei
    Aliev, Alexander
    PROBASTAT '11: PROCEEDINGS OF THE SIXTH INTERNATIONAL CONFERENCE ON PROBABILITY AND STATISTICS: DEDICATED TO PROFESSOR LUBOMIR KUBACEK IN RECOGNITION OF HIS EIGHTIETH BIRTHDAY, 2012, 51 : 115 - +
  • [3] Sample Size Computations for PK/PD Population Models
    Dongwoo Kang
    Janice B. Schwartz
    Davide Verotta
    Journal of Pharmacokinetics and Pharmacodynamics, 2005, 32 : 685 - 701
  • [4] Sample size computations for PK/PD population models
    Kang, D
    Schwartz, JB
    Verotta, D
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2005, 32 (5-6) : 685 - 701
  • [5] Fast screening of covariates in population models empowered by machine learning
    Emeric Sibieude
    Akash Khandelwal
    Jan S. Hesthaven
    Pascal Girard
    Nadia Terranova
    Journal of Pharmacokinetics and Pharmacodynamics, 2021, 48 : 597 - 609
  • [6] Fast screening of covariates in population models empowered by machine learning
    Sibieude, Emeric
    Khandelwal, Akash
    Hesthaven, Jan S.
    Girard, Pascal
    Terranova, Nadia
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2021, 48 (04) : 597 - 609
  • [7] An examination of approaches for screening covariates as part of PK/PD modeling
    Burstein, AH
    Collins, DA
    Forrest, A
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1996, 59 (02) : PI102 - PI102
  • [8] Bayesian analysis of population PK/PD models: General concepts and software
    Lunn, DJ
    Best, N
    Thomas, A
    Wakefield, J
    Spiegelhalter, D
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2002, 29 (03) : 271 - 307
  • [9] Population PK/PD of Albiglutide
    Wald, J. A.
    Young, M. A.
    Reinhardt, R.
    Budda, B.
    Watanalumlerd, P.
    Smith, C.
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2014, 41 : S65 - S65
  • [10] Simple sample size calculation for population PK/PD models.
    Kang, D
    Verotta, D
    Schwartz, JB
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2002, 71 (02) : P74 - P74